Journal Article

Syntenin-1-mediated arthritogenicity is advanced by reprogramming RA metabolic macrophages and Th1 cells

Lewis, Myles, Al-Awqati, Mina, Jetanalin, Pim, Schett, Georg, Shahrara, Shiva, Chang, Huan J, Nijim, Wes, Arami, Shiva, Pitzalis, Costantino, Sienes, Ryan E, Volin, Michael V, Umar, Sadiq, Sweiss, Nadera, Meyer, Anja, Zanotti, Brian, Van Raemdonck, Katrien

2023

Overview

ObjectivesSyntenin-1, a novel endogenous ligand, was discovered to be enriched in rheumatoid arthritis (RA) specimens compared with osteoarthritis synovial fluid and normal synovial tissue (ST). However, the cellular origin, immunoregulation and molecular mechanism of syntenin-1 are undescribed in RA.MethodsRA patient myeloid and lymphoid cells, as well as preclinical models, were used to investigate the impact of syntenin-1/syndecan-1 on the inflammatory and metabolic landscape.ResultsSyntenin-1 and syndecan-1 (SDC-1) co-localise on RA ST macrophages (MΦs) and endothelial cells. Intriguingly, blood syntenin-1 and ST SDC-1 transcriptome are linked to cyclic citrullinated peptide, erythrocyte sedimentation rate, ST thickness and bone erosion. Metabolic CD14+CD86+GLUT1+MΦs reprogrammed by syntenin-1 exhibit a wide range of proinflammatory interferon transcription factors, monokines and glycolytic factors, along with reduced oxidative intermediates that are downregulated by blockade of SDC-1, glucose uptake and/or mTOR signalling. Inversely, IL-5R and PDZ1 inhibition are ineffective on RA MΦs-reprogrammed by syntenin-1. In syntenin-1-induced arthritis, F4/80+iNOS+RAPTOR+MΦs represent glycolytic RA MΦs, by amplifying the inflammatory and glycolytic networks. Those networks are abrogated in SDC-1-/- animals, while joint prorepair monokines are unaffected and the oxidative metabolites are moderately replenished. In RA cells and/or preclinical model, syntenin-1-induced arthritogenicity is dependent on mTOR-activated MΦ remodelling and its ability to cross-regulate Th1 cells via IL-12 and IL-18 induction. Moreover, RA and joint myeloid cells exposed to Syntenin-1 are primed to transform into osteoclasts via SDC-1 ligation and RANK, CTSK and NFATc1 transcriptional upregulation.ConclusionThe syntenin-1/SDC-1 pathway plays a critical role in the inflammatory and metabolic landscape of RA through glycolytic MΦ and Th1 cell cross-regulation (graphical abstract).

• Publisher: BMJ Publishing Group Ltd and European League Against Rheumatism,Elsevier Limited
• Subject: Animals / Antibodies / Arthritis, Rheumatoid / Blood vessels / Cancer / CD14 antigen / CD86 antigen / Cell adhesion & migration / Citrulline / Endothelial cells / Endothelial Cells - metabolism / Glycolysis / Histology / Humans / Immunoregulation / Inflammation / Interleukin 12 / Interleukin 18 / Interleukin 5 receptors / Intermediates / Kinases / Ligands / Lymphocytes T / Lymphoid cells / Macrophages / Macrophages - metabolism / Melanoma / Metabolism / Metabolites / Metastasis / Monokines / Monokines - metabolism / Myeloid cells / Nitric-oxide synthase / Osteoarthritis / Osteoclasts / Proteins / Rheumatoid arthritis / Signal transduction / Syndecan / Syndecan-1 - metabolism / Synovial fluid / Synovial Fluid - metabolism / Synovial Membrane - metabolism / Syntenins - metabolism / T-Lymphocyte subsets / Th1 Cells / TOR protein / TOR Serine-Threonine Kinases / Transcription factors / Ultrasonic imaging